Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle Breastfeeding

Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle while breastfeeding. We will also discuss about common side effects and warnings associated with Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle.

What is Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle used for?


Fenofibrate tablets are a peroxisome proliferator receptor alpha (PPARĪ±) activator indicated as an adjunct to diet: To reduce elevated LDL-C, Total-C, TG, and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. ( 1.1) For treatment of adult patients with severe hypertriglyceridemia. ( 1.2) Important Limitations of Use: Fenofibrate was not shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus. ( 5.1) 1.1 Primary Hypercholesterolemia or Mixed Dyslipidemia Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia or mixed dyslipidemia. 1.2 Severe Hypertriglyceridemia Fenofibrate tablets are also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. Improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention. Markedly elevated levels of serum triglycerides (e.g. >2000 mg/dL) may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been adequately studied. 1.3 Important Limitations of Use Fenofibrate at a dose equivalent to 145 mg of fenofibrate tablets was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes mellitus [see Warnings and Precautions ( 5.1)].

I am currently breastfeeding and I want to know if using Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle is safe for my kid? Does it have any effect on milk production?

Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle low risk for breastfeeding
Fenofibrate is the one and only active ingredient present in Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle. Fenofibrate in itself is a low risk drug for lactation so it is easy to understand that Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle also comes in category of Low Risk item while breastfeeding. Below is the summary of Fenofibrate in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Fenofibrate should not be used in nursing mothers. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle Breastfeeding Analsys


Fenofibrate while Breastfeeding

Low Risk

CAS Number: 49562-28-9

Fenofibrate, like other fibrates, decreases elevated blood lipids (triglycerides and cholesterol) by increasing the activity of lipases that catabolize triglyceride-rich lipoproteins and slightly decreasing cholesterol biosynthesis (AEMPS 2017, BGP 2015, Miller 1998). In general, fibrates have a discrete effect on the increase of high density lipoprotein (HDL) concentration and the reduction of low density lipoprotein (LDL). Since the last update we have not found published data in relation to breastfeeding. Its high binding to plasma proteins makes it unlikely it will pass into breast milk. Cholesterol levels in milk are very stable even in hypercholesterolemic women and are not severely affected by diet or nutritional status of the mother, suggesting that 3 is synthesized, at least in part, in the mammary gland (Lawrence 2016, p 289-90).It is not probable therefore, but it is not known if the fibrates are able to alter the lipid composition of the milk. Infants need to ingest large amounts of cholesterol, as it is critical to the proper development of the nervous system, cell membranes and is a precursor of several hormones and vitamins. Until there is more data in relation to breastfeeding, it is prudent to avoid using it, at least while breastfeeding exclusively. Suspending the pharmacological treatment of hyperlipidemia during breastfeeding is not likely to alter the long-term outcome of the disease, especially when breastfeeding can be considered therapeutic (Lawrence 2016, p.393). It is advisable to follow a lipid-lowering diet. In case of administering a fibrate during breastfeeding it is advisable to choose those with a shorter half-life: bezafibrate, gemfibrozil.


Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle Breastfeeding Analsys - 2


Fenofibrate while Breastfeeding

CAS Number: 49562-28-9

No relevant published information exists on the use of fenofibrate during breastfeeding. Because of a concern with disruption of infant lipid metabolism, fenofibrate is best avoided during breastfeeding. An alternate drug is preferred, especially while nursing a newborn or preterm infant. The manufacturer recommends that breastfeeding be avoided during fenofibrate therapy and for 5 days after the final dose.



What should I do if already breastfed my kid after using Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle?

Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle so you should inform him based on your convenience.


My health care provider has asked me to use Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle, what to do?

Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle, will my baby need extra monitoring?

Not much monitoring required while using Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle


Who can I talk to if I have questions about usage of Fenofibrate 20 In 1 Bottle, 30 In 1 Bottle in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week